Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Programme
Postgraduate Teaching
Industry
Supporters
CME Accreditation
Congress Resources
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Funding for guideline updates
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Session
IBD (Posters)
ANCA-ASSOCIATED VASCULITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: ONE OF THE PREDICTORS OF SEVERE COURSE AND REASONS FOR NON-RESPONSE TO BASIC THERAPY
IBD (Posters)
et al.
COMPARATIVE ASSESSMENT OF INFLIXIMAB TROUGH LEVELS BETWEEN POINT-OF-CARE TESTING AND CURRENT STANDARD OF CARE (ENZYME LINKED IMMUNOSORBENT ASSAY) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
IBD (Posters)
et al.
A PILOT STUDY ON THE USE OF USTEKINUMAB IN REFRACTORY PERIANAL CROHN’S DISEASE
IBD (Posters)
et al.
PREVALENCE OF FIRST TIME SURGERY AMONGST INFLAMMATORY BOWEL DISEASE PATIENTS AT A DISTRICT GENERAL HOSPITAL: A 25 YEAR RETROSPECTIVE REVIEW
IBD (Posters)
et al.
REDO-SURGERY IN IBD PATIENTS: WHAT IS THE TIME INTERVAL AND IS THIS EFFECTED BY SPECIFIC RISK FACTORS?
IBD (Posters)
et al.
PLATELET-TO-LYMPHOCYTE RATIO INDEX: STILL NOT ABOVE FECAL CALPROTECTIN FOR NON-INVASIVE ASSESSMENT OF ENDOSCOPIC ACTIVITY IN ULCERATIVE COLITIS
IBD (Posters)
et al.
THE CHANGING TRENDS SEEN WITH SURGERY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE OVER A 25 YEAR REVIEW PERIOD
IBD (Posters)
et al.
DOES THE TYPE OF SURGERY OR DISEASE LOCATION PREDICT THE NEED FOR SUBSEQUENT SURGERIES, IN IBD PATIENTS
IBD (Posters)
et al.
MIRIKIZUMAB THERAPY IS ASSOCIATED WITH IMPROVED FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
IBD (Posters)
et al.
CHARACTERISTICS AND REAL WORLD TREATMENT HISTORY OF PATIENTS TREATED WITH TOFACITINIB FOR ULCERATIVE COLITIS IN EUROPE
IBD (Posters)
et al.
INCIDENCE, CLINICAL PRESENTATION, AND SEVERITY OF SARS-COV-2 INFECTION IN INFLAMMATORY BOWEL DISEASE PATIENTS IN THE “SECOND AND THE THIRD WAVE” OF INFECTION
IBD (Posters)
et al.
PREVALENCE AND RISK FACTORS FOR MALIGNANCY IN INFLAMMATORY BOWEL DISEASE
IBD (Posters)
et al.
EFFICACY OF SUBCUTANEOUS INFLIXIMAB IN PERIANAL CROHN’S DISEASE
IBD (Posters)
et al.
THE INFLAMMATORY BOWEL DISEASE – DISK TOOL FOR ASSESSING DISABILITY IN INFLAMMATORY BOWEL DISEASE PATIENTS: VALIDATION OF THE GREEK VERSION
IBD (Posters)
et al.
MANAGEMENT AND OUTCOME OF POSTOPERATIVE CROHN’S DISEASE IN THE ELDERLY AS COMPARED TO YOUNG ADULTS: DATA FROM ENEIDA REGISTRY
IBD (Posters)
et al.
SAFETY OF CONCURRENT ADMINISTRATION OF OZANIMOD AND SEROTONERGIC ANTIDEPRESSANTS IN PATIENTS WITH ULCERATIVE COLITIS
IBD (Posters)
et al.
LONG-TERM SAFETY OF OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (UC) AND RELAPSING MULTIPLE SCLEROSIS (RMS) STUDIES
IBD (Posters)
et al.
THERAPEUTIC DRUG MONITORING: PERFORMANCE OF THE FIRST LATERAL FLOW-BASED POINT OF CARE TEST FOR THE QUANTIFICATION OF INFLIXIMAB IN A FINGER PRICK
IBD (Posters)
et al.
CORRELATION OF THE FIRST LATERAL FLOW-BASED POINT OF CARE TEST TO QUANTIFY INFLIXIMAB AND ANTI-INFLIXIMAB ANTIBODIES IN A FINGER PRICK SAMPLE WITH THE REFERENCE ELISA TECHNIQUE
IBD (Posters)
et al.
IMPACT OF MIRIKIZUMAB THERAPY ON HISTOLOGIC MEASURES OF INTESTINAL INFLAMMATION IN A PHASE 2 STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
IBD (Posters)
et al.
Item 381 - 400 / 568
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Chat with us
, powered by
LiveChat